Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Metzeler KH"'
Autor:
Chacon, D, Braytee, A, Huang, Y, Thoms, J, Subramanian, S, Sauerland, MC, Bohlander, SK, Braess, J, Woermann, BJ, Berdel, WE, Hiddemann, W, Gabrys, B, Metzeler, KH, Herold, T, Pimanda, J, Beck, D
Background: Acute myeloid leukemia (AML) is a highly heterogeneous malignancy and risk stratification based on genetic and clinical variables is standard practice. However, current models incorporating these factors accurately predict clinical outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::eecc9e63048170633577b6cb01b571f5
https://hdl.handle.net/10453/158862
https://hdl.handle.net/10453/158862
Autor:
Rao, AV, Valk, Peter, Metzeler, KH, Acharya, CR, Tuchman, SA, Stevenson, MM, Rizzieri, DA, Delwel, Ruud, Buske, C, Bohlander, SK, Potti, A, Löwenberg, Bob
Publikováno v:
Journal of Clinical Oncology, 27(33), 5580-5586. American Society of Clinical Oncology
Purpose To define the biology driving the aggressive nature of acute myeloid leukemia (AML) in elderly patients. Patients and Methods Clinically annotated microarray data from 425 patients with newly diagnosed de novo AML from two publicly available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::f6db13c4b1f47c9d85ce05acac94070c
https://pure.eur.nl/en/publications/ef1e4493-a50f-486b-a62b-f1a06fbacca7
https://pure.eur.nl/en/publications/ef1e4493-a50f-486b-a62b-f1a06fbacca7
Autor:
Metzeler KH, Dufour A, Benthaus T, Hummel M, Sauerland MC, Heinecke A, Berdel WE, Büchner T, Wörmann B, Mansmann U, Braess J, Spiekermann K, Hiddemann W, Buske C, Bohlander SK, Metzeler, Klaus H, Dufour, Annika, Benthaus, Tobias, Hummel, Manuela, Sauerland, Maria-Cristina
Publikováno v:
Journal of Clinical Oncology; 10/20/2009, Vol. 27 Issue 30, p5031-5038, 8p
Autor:
Fandrei D; University Hospital Leipzig, Leipzig, Germany., Seiffert S; University Hospital Leipzig, Germany., Rade M; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany., Rieprecht S; University Hospital Leipzig, Leipzig, Germany., Gagelmann N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Born P; University Hospital Leipzig, Germany., Wiemers T; University Hospital Leipzig, Leipzig, Germany., Weidner H; University Hospital Leipzig, Leipzig, Germany., Kreuz M; Fraunhofer Institute for Cell Therapy and Immunology, Department of Diagnostics, Leipzig, Germany, Germany., Schassberger T; University Hospital Leipzig, Germany., Kossmann J; University Hospital Leipzig, Germany., Mangold M; University Hospital Leipzig, Germany., Furst D; University Hospital Ulm, Germany., Fischer L; University Hospital Carl Gustav Carus, Dresden, Germany., Baber R; University Hospital Leipzig, Germany., Heyn S; University Hospital Leipzig, Germany., Wang SY; University Hospital Leipzig, Germany., Bach E; University Hospital Leipzig, Germany., Hoffmann S; University Hospital Leipzig, Germany., Metzeler KH; University of Leipzig, Leipzig, Germany., Herlling M; University Hospital Leipzig, Germany., Jentzsch M; Universiy of Leipzig, Leipzig, Germany., Franke GN; Universiy of Leipzig, Leipzig, Germany., Kohl U; University Hospital Leipzig, Germany., Friedrich M; University Hospital Leipzig, Leipzig, Germany., Boldt A; University Hospital Leipzig, Germany., Reiche K; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany., Platzbecker U; University Hospital Leipzig, Leipzig, Germany., Vucinic V; Universiy of Leipzig, Leipzig, Germany., Merz M; University Hospital Leipzig, Leipzig, Germany.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2024 Oct 23. Date of Electronic Publication: 2024 Oct 23.
Autor:
Rade M; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany., Grieb N; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany.; Innovation Center Computer Assisted Surgery, University Hospital of Leipzig, Leipzig, Germany., Weiss R; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Institute for Clinical Immunology, University Hospital of Leipzig, Leipzig, Germany., Sia J; Singleron Biotechnologies, Cologne, Germany., Fischer L; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Born P; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Boldt A; Institute for Clinical Immunology, University Hospital of Leipzig, Leipzig, Germany., Fricke S; Institute for Clinical Immunology, University Hospital of Leipzig, Leipzig, Germany., Franz P; Institute for Clinical Immunology, University Hospital of Leipzig, Leipzig, Germany., Scolnick J; Singleron Biotechnologies, Cologne, Germany., Venkatraman L; Singleron Biotechnologies, Cologne, Germany., Xu S; Singleron Biotechnologies, Cologne, Germany., Kloetzer C; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Heyn S; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Kubasch AS; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Baber R; Institute for Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany.; Leipzig Medical Biobank, University Leipzig, Leipzig, Germany., Wang SY; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Bach E; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Hoffmann S; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Ussmann J; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Schetschorke B; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Hell S; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Schwind S; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Metzeler KH; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Herling M; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Jentzsch M; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Franke GN; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Sack U; Institute for Clinical Immunology, University Hospital of Leipzig, Leipzig, Germany., Köhl U; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Institute for Clinical Immunology, University Hospital of Leipzig, Leipzig, Germany., Platzbecker U; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Reiche K; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Institute for Clinical Immunology, University Hospital of Leipzig, Leipzig, Germany.; Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI), Dresden, Leipzig, Germany., Vucinic V; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany., Merz M; Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany. maximilian.merz@medizin.uni-leipzig.de.
Publikováno v:
Nature cancer [Nat Cancer] 2024 Sep; Vol. 5 (9), pp. 1318-1333. Date of Electronic Publication: 2024 Apr 19.
Autor:
Hernández-Sánchez A; Hematology Department, University Hospital of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain., González T; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain., Sobas M; Wroclaw Medical University, Wroclaw, Poland., Sträng E; Charité Universitätsmedizin Berlin, Berlin, Germany., Castellani G; DIMES, University of Bologna, Bologna, Italy., Abáigar M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain., Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Villaverde Ramiro Á; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Metzeler KH; University of Leipzig, Leipzig, Germany., Azibeiro R; Hematology Department, University Hospital of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Tettero JM; Department of Hematology, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Martínez-López J; Hospital Universitario 12 de Octubre, Madrid, Spain., Pratcorona M; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Martínez Elicegui J; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain., Mills KI; Patrick G Johnston Centre for Cancer Research, Queen's University, Belfast, UK., Thiede C; University of Technics Dresden Medical Department, Dresden, Germany., Sanz G; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Turki AT; Marienhospital University Hospital, Ruhr-University Bochum, Bochum, Germany.; Universitätsklinikum Essen, Essen, Germany., Reinhardt D; Department of Pediatrics III, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Schulze-Rath R; Bayer AG, Pharmaceuticals Division, Berlin, Germany., Barbus M; AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany., Hernández-Rivas JM; Hematology Department, University Hospital of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center of Salamanca (IBMCC, USAL-CSIC), Salamanca, Spain.; Department of Medicine, University of Salamanca, Salamanca, Spain., Huntly B; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Ossenkoppele G; Department of Hematology, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany. lars.bullinger@charite.de.
Publikováno v:
Leukemia [Leukemia] 2024 Sep; Vol. 38 (9), pp. 1929-1937. Date of Electronic Publication: 2024 Jul 04.
Autor:
Halik A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Tilgner M; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Silva P; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Estrada N; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Altwasser R; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Jahn E; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Department of Internal Medicine IV, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany., Hou HA; Division of Hematology, Department of Internal Medicine, and Division of General Medicine, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung Shan South Road, Taipei City, Taiwan., Pratcorona M; Hospital de la Santa Creu i Sant Pau. Institut de Recerca Sant Pau. Department of Medicine, Universitat Autonoma of Barcelona, Barcelona, Spain., Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Metzeler KH; Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany., Fenwarth L; Unité Mixte de Recherche (UMR) 9020-UMR1277, Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, University of Lille, Centre National de la Recherche Scientifique (CNRS), INSERM, Centre Hospitalo-Universitaire (CHU) Lille, Institut de Recherche sur le Cancer de Lille (IRCL), Lille, France., Dolnik A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Terre C; Laboratoire de Cytogénétique, Service de Biologie, CH de Versailles, Le Chesnay, France., Kopp K; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Blau O; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Szyska M; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Christen F; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Krönke J; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany., Vasseur L; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France., Löwenberg B; Department of Hematology, Erasmus MC Cancer Institute, and Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Esteve J; Hematology Department, IDIBAPS, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain., Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, and Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Duchmann M; Institut de Recherche Saint-Louis (IRSL), Institut National de la Santé et de la Recherche Médicale (INSERM) U944, Centre National de la Recherche Scientifique (CNRS) UMR 7212 GenCellDis, Université Paris Cité, Paris, France., Chou WC; Division of Hematology, Department of Internal Medicine, and Division of General Medicine, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung Shan South Road, Taipei City, Taiwan., Linch DC; Department of Haematology, University College London Cancer Institute, London, UK., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Gale RE; Department of Haematology, University College London Cancer Institute, London, UK., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany., Yoshida K; Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan., Damm F; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. frederik.damm@charite.de.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany. frederik.damm@charite.de.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Aug 19; Vol. 17 (1), pp. 70. Date of Electronic Publication: 2024 Aug 19.
Autor:
Archer KJ; Division of Biostatistics, College of Public Health, The Ohio State University, 240 Cunz Hall, 1841 Neil Avenue, Columbus, OH, 43210, USA. archer.43@osu.edu., Fu H; Google, Inc., Mountain View, CA, USA., Mrózek K; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Nicolet D; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Alliance Statistics and Data Management Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Mims AS; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Uy GL; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA., Stock W; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA., Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany., Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Metzeler KH; Department of Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany., Herold T; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Eisfeld AK; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 May 03; Vol. 17 (1), pp. 28. Date of Electronic Publication: 2024 May 03.
Autor:
Winter S; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany., Götze KS; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; German MDS Study Group (D-MDS), Leipzig, Germany., Hecker JS; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany., Metzeler KH; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University of Leipzig Medical Center, Leipzig, Germany., Guezguez B; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology and Oncology, University Medical Center Mainz, Mainz, Germany., Woods K; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology and Oncology, University Medical Center Mainz, Mainz, Germany., Medyouf H; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Frankfurt am Main, Germany., Schäffer A; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany., Schmitz M; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Wehner R; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Glauche I; Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany., Roeder I; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany., Rauner M; Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine III, and Center for Healthy Aging, University Medical Center, TU Dresden, Dresden, Germany., Hofbauer LC; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Lorenz.Hofbauer@ukdd.de.; Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine III, and Center for Healthy Aging, University Medical Center, TU Dresden, Dresden, Germany. Lorenz.Hofbauer@ukdd.de., Platzbecker U; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites Dresden/Munich/Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Uwe.Platzbecker@medizin.uni-leipzig.de.; German MDS Study Group (D-MDS), Leipzig, Germany. Uwe.Platzbecker@medizin.uni-leipzig.de.; Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University of Leipzig Medical Center, Leipzig, Germany. Uwe.Platzbecker@medizin.uni-leipzig.de.
Publikováno v:
Leukemia [Leukemia] 2024 May; Vol. 38 (5), pp. 936-946. Date of Electronic Publication: 2024 Mar 21.
Autor:
Schwind S; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Bischof L; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Bill M; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Grimm J; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Ussmann J; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Backhaus D; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Brauer D; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Thanh TP; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Merz M; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Franke GN; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Metzeler KH; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Vucinic V; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Herling M; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Platzbecker U; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany., Jentzsch M; Medical Clinic and Policlinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases Leipzig University Hospital Leipzig Germany.
Publikováno v:
HemaSphere [Hemasphere] 2024 Mar 18; Vol. 8 (3), pp. e55. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).